Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Core Insights - Axogen, Inc. has appointed Jesse Bishop as Vice President of Regulatory Affairs to lead regulatory strategies for new product development and market approval [1][2][5] - Mr. Bishop brings over 13 years of experience in regulatory strategy and has previously worked with notable companies in the medical field [4][5] - Axogen focuses on innovative surgical solutions for peripheral nerve injuries, aiming to restore nerve function and improve patient quality of life [7][8] Company Overview - Axogen is a leader in the development and commercialization of technologies for peripheral nerve regeneration and repair [7] - The company offers a comprehensive portfolio of products for both scheduled and emergent trauma procedures related to peripheral nerve injuries [8][10] - Axogen's product offerings include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, and Axoguard Nerve Cap, which are available in multiple countries [10] Regulatory Affairs - Mr. Bishop will oversee all aspects of Axogen's regulatory affairs, including product registrations and interactions with regulatory agencies [3] - He will also work on developing regulatory policy in collaboration with external groups such as the Alliance for Regenerative Medicine and the American Association of Tissue Banks [3] Employment Inducement - As part of his employment, Mr. Bishop will receive an equity grant of 45,000 shares of Axogen common stock, with a vesting schedule over four years [6]